Eagle Pharmaceuticals (EGRX) Reports Prelim. 3Q EPS Above Consenus, Prelim. 3Q Revenues Below Consensus

Go back to Eagle Pharmaceuticals (EGRX) Reports Prelim. 3Q EPS Above Consenus, Prelim. 3Q Revenues Below Consensus
EAGLE PHARMACEUT (NASDAQ: EGRX) Delayed: 2.14 --0 (-0%)
Previous Close $2.14    52 Week High $102.48 
Open $2.14    52 Week Low $33.02 
Day High $2.14    P/E N/A 
Day Low $2.14    EPS $-1.02 
Volume 265,930